# Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

> **NCT06282458** · PHASE2 · COMPLETED · sponsor: **Veru Inc.** · enrollment: 168 (actual)

## Conditions studied

- Muscle Loss
- Obesity

## Interventions

- **DRUG:** Enobosarm
- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT06282458
- **Lead sponsor:** Veru Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-29
- **Primary completion:** 2025-04-11
- **Final completion:** 2025-08-22
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282458, "Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06282458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*